U.S. stocks were lower, with the Nasdaq Composite falling more than 100 points on Monday.
Shares of Kyverna Therapeutics Inc (NASDAQ:KYTX) rose sharply during Monday's session after the company announced topline data from KYSA-8.
The clinical-stage biopharmaceutical company shared topline data from the KYSA-8 Phase 2 trial of mivocabtagene autoleucel (miv-cel, formerly KYV-101) in stiff person syndrome (SPS).
Miv-cel is a fully human, autologous CD19-targeting CAR T-cell therapy with CD28 co-stimulation.
Kyverna Therapeutics shares jumped 31% to $11.49 on Monday.
Here are some other big stocks recording gains in today’s session.
- Beneficient (NASDAQ:BENF) gained 29.3% to $6.21.
- Immunome Inc (NASDAQ:IMNM) surged 25.5% to $24.56 after announcing positive topline results from Phase 3 RINGSIDE trial of Varegacestat in patients with Desmoid Tumors.
- Falcon’s Beyond Global Inc (NASDAQ:FBYD) gained 14% to $12.83.
- XBP Global Holdings Inc (NASDAQ:XBP) surged 11.5% to $6.39.
- Almonty Industries Inc (NASDAQ:ALM) gained 9.1% to $7.38 as the company announced voluntary withdrawal of base shelf prospectus and registration statement.
- Ur-Energy Inc (NYSE:URG) gained 8.6% to $1.39.
- NovaBay Pharmaceuticals Inc (NYSE:NBY) shares jumped 7.1% to $3.00.
- AXT Inc (NASDAQ:AXTI) rose 7.1% to $15.88.
- Olema Pharmaceuticals Inc (NASDAQ:OLMA) jumped 6.8% to $35.30.
- Silvercorp Metals Inc (NYSE:SVM) gained 6.4% to $8.65.
- Standard Lithium Ltd (NYSE:SLI) surged 6.3% to $4.91.
- ZIM Integrated Shipping Services Ltd (NYSE:ZIM) gained 4.8% to $19.64.
Read This Next:
Photo via Shutterstock
© 2025 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
